Published in Arch Ophthalmol on October 01, 2002
PAIR Study-PAP And IOP Relationship: Study 1 (PAIR) | NCT03127813
Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol (2004) 5.44
Primary open-angle glaucoma. N Engl J Med (2009) 4.89
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol (2012) 3.93
The pathophysiology and treatment of glaucoma: a review. JAMA (2014) 3.15
Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology (2014) 2.93
Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14
Correcting motion artifacts in retinal spectral domain optical coherence tomography via image registration. Med Image Comput Comput Assist Interv (2009) 2.06
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ (2005) 2.03
African Ancestry Is Associated with Higher Intraocular Pressure in Latinos. Ophthalmology (2015) 2.01
Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology (2011) 2.01
Automated segmentation of the optic disc from stereo color photographs using physiologically plausible features. Invest Ophthalmol Vis Sci (2007) 1.97
Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A (2010) 1.96
Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol (2006) 1.83
Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol (2005) 1.80
Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology (2011) 1.70
Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ophthalmology (2005) 1.59
Diagnostic tools for glaucoma detection and management. Surv Ophthalmol (2008) 1.58
Automated segmentation of neural canal opening and optic cup in 3D spectral optical coherence tomography volumes of the optic nerve head. Invest Ophthalmol Vis Sci (2010) 1.58
Automated segmentation of the cup and rim from spectral domain OCT of the optic nerve head. Invest Ophthalmol Vis Sci (2009) 1.56
High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci U S A (2005) 1.55
Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force. Ann Fam Med (2005) 1.55
Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol Vis Sci (2012) 1.53
'Structure-function relationship' in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol (2012) 1.53
Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness. Br J Ophthalmol (2004) 1.52
Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proc Natl Acad Sci U S A (2009) 1.51
Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension. Clin Ophthalmol (2013) 1.48
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol (2015) 1.46
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol (2010) 1.45
The medical and surgical treatment of glaucoma. Dtsch Arztebl Int (2009) 1.44
Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users. Graefes Arch Clin Exp Ophthalmol (2009) 1.40
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems. PLoS One (2015) 1.40
Differences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma. Int Ophthalmol (2014) 1.40
Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res (2012) 1.40
Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Invest (2008) 1.39
[Functional glaucoma diagnosis]. Ophthalmologe (2009) 1.38
Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One (2012) 1.35
A comparison of four methods of tonometry: method agreement and interobserver variability. Br J Ophthalmol (2005) 1.32
Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma. J Neurosci (2013) 1.31
Sustained stress response after oxidative stress in trabecular meshwork cells. Mol Vis (2007) 1.30
Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience (2010) 1.29
Effect of acute intraocular pressure elevation on the monkey optic nerve head as detected by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.28
The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents. Biomaterials (2011) 1.28
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers. J Neuroinflammation (2014) 1.26
Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci (2012) 1.25
Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci (2007) 1.23
Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma? Clin Ophthalmol (2008) 1.21
Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci (2005) 1.19
Determinants of medication adherence to topical glaucoma therapy. J Glaucoma (2012) 1.19
Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Br J Ophthalmol (2006) 1.18
Lower corneal hysteresis in glaucoma patients with acquired pit of the optic nerve (APON). Graefes Arch Clin Exp Ophthalmol (2008) 1.17
Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci (2007) 1.17
A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol (2011) 1.15
Evaluation of peripapillary choroidal thickness in patients with normal-tension glaucoma. BMC Ophthalmol (2012) 1.14
Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet (2014) 1.13
Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp Eye Res (2010) 1.13
Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol Cell Biol (2006) 1.11
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 1.10
Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS One (2012) 1.10
Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model. Mol Vis (2012) 1.09
Determinants and heritability of intraocular pressure and cup-to-disc ratio in a defined older population. Ophthalmology (2005) 1.08
Glaucoma management in Sweden -- results from a nationwide survey. Acta Ophthalmol (2011) 1.07
Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol (2012) 1.07
Effect of intraocular pressure on the Bayesian estimation of rates of visual field progression in glaucoma. Invest Ophthalmol Vis Sci (2013) 1.06
Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One (2014) 1.06
Glaucoma follow-up by the Heidelberg retina tomograph--new graphical analysis of optic disc topography changes. Graefes Arch Clin Exp Ophthalmol (2005) 1.06
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study. BMC Health Serv Res (2007) 1.05
Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2012) 1.05
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener (2011) 1.05
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol (2006) 1.05
Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer over a wide IOP range. Graefes Arch Clin Exp Ophthalmol (2008) 1.05
Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol (2016) 1.04
Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma. Invest Ophthalmol Vis Sci (2013) 1.04
Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev (2010) 1.03
Incorporating risk factors to improve the assessment of rates of glaucomatous progression. Invest Ophthalmol Vis Sci (2012) 1.02
Performance of glaucoma progression analysis software in a glaucoma population. Graefes Arch Clin Exp Ophthalmol (2008) 1.02
Chronically implanted pressure sensors: challenges and state of the field. Sensors (Basel) (2014) 1.02
International vision requirements for driver licensing and disability pensions: using a milestone approach in characterization of progressive eye disease. Clin Ophthalmol (2010) 1.01
Practical approach to medical management of glaucoma. Indian J Ophthalmol (2008) 1.01
Reliability and sensitivity of the TonoLab rebound tonometer in awake Brown Norway rats. Invest Ophthalmol Vis Sci (2009) 1.01
Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet (2014) 1.00
Glaucoma prescribing trends in England 2000 to 2012. Eye (Lond) (2014) 1.00
Compliance and adherence in glaucoma management. Indian J Ophthalmol (2011) 1.00
Biomarkers and surrogate endpoints in glaucoma clinical trials. Br J Ophthalmol (2014) 0.99
Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day. Clin Ophthalmol (2012) 0.99
Solving the lost in translation problem: improving the effectiveness of translational research. Curr Opin Pharmacol (2012) 0.98
The utilization of eye care services by persons with glaucoma in rural south India. Trans Am Ophthalmol Soc (2004) 0.98
Vascular risk factors in glaucoma: the results of a national survey. Graefes Arch Clin Exp Ophthalmol (2006) 0.97
The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J Ocul Pharmacol Ther (2014) 0.97
Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag (2006) 0.97
Association between visual field defects and quality of life in the United States. Ophthalmology (2013) 0.97
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res (2011) 0.97
Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol (2004) 0.97
Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom. Br J Ophthalmol (2004) 0.96
Effect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial. BMJ (2006) 0.96
Patient persistence with first-line antiglaucomatous monotherapy. Clin Ophthalmol (2010) 0.96
Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol (2006) 0.95
Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix. Invest Ophthalmol Vis Sci (2013) 0.95
Latanoprost in the treatment of glaucoma. Clin Ophthalmol (2014) 0.95
Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2015) 0.95
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol (2004) 5.44
Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology (2007) 4.79
A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci (2003) 3.60
Natural history of open-angle glaucoma. Ophthalmology (2009) 2.99
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology (2006) 2.66
Electric blanket use and breast cancer on Long Island. Epidemiology (2003) 2.06
Corneal thickness and intraocular pressure in the Barbados eye studies. Arch Ophthalmol (2003) 2.05
Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand (2003) 1.96
Patient-reported reasons for discontinuing overactive bladder medication. BJU Int (2009) 1.94
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Invest Ophthalmol Vis Sci (2004) 1.69
Diabetes in a Caribbean population: epidemiological profile and implications. Int J Epidemiol (2002) 1.68
Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol (2004) 1.52
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
Side effects, complications and outcome of thoracoscopic sympathectomy for palmar and axillary hyperhidrosis in 406 patients. Eur J Cardiothorac Surg (2008) 1.41
Incident open-angle glaucoma and ocular perfusion pressure. Invest Ophthalmol Vis Sci (2011) 1.40
Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis (2012) 1.38
Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol (2004) 1.34
Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol (2006) 1.31
Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Invest Ophthalmol Vis Sci (2002) 1.31
Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados. Proc Natl Acad Sci U S A (2009) 1.30
Incident open-angle glaucoma and intraocular pressure. Ophthalmology (2007) 1.27
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol (2007) 1.26
Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology (2003) 1.21
Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology (2005) 1.21
A genome-wide scan for primary open-angle glaucoma (POAG): the Barbados Family Study of Open-Angle Glaucoma. Hum Genet (2003) 1.21
Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology (2004) 1.19
Modelling the normal retinal nerve fibre layer thickness as measured by Stratus optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2006) 1.19
Awareness of incident open-angle glaucoma in a population study: the Barbados Eye Studies. Ophthalmology (2007) 1.18
Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol (2012) 1.17
Repeatability of ETDRS visual acuity in children. Invest Ophthalmol Vis Sci (2003) 1.16
CDKN2B polymorphism is associated with primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. PLoS One (2012) 1.16
Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the correction of myopia evaluation trial. Arch Ophthalmol (2005) 1.15
Population-based studies in ophthalmology. Am J Ophthalmol (2008) 1.14
Glaucoma detection by Stratus OCT. J Glaucoma (2007) 1.13
Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology (2005) 1.13
TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complications (2008) 1.12
A genome-wide association study of breast cancer in women of African ancestry. Hum Genet (2012) 1.11
Trained artificial neural network for glaucoma diagnosis using visual field data: a comparison with conventional algorithms. J Glaucoma (2007) 1.10
Public-academic partnerships: early intervention for psychotic disorders in a community mental health center. Psychiatr Serv (2009) 1.09
Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology (2008) 1.09
A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand (2002) 1.08
Glaucoma management in Sweden -- results from a nationwide survey. Acta Ophthalmol (2011) 1.07
Prostate cancer incidence and mortality in barbados, west indies. Prostate Cancer (2011) 1.07
Nine-year incidence and risk factors for pterygium in the barbados eye studies. Ophthalmology (2008) 1.04
Solo ultrasonography-guided percutanous nephrolithotomy for single stone pelvis. J Endourol (2011) 1.04
Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol (2013) 1.03
Impact of glaucoma, lens opacities, and cataract surgery on visual functioning and related quality of life: the Barbados Eye Studies. Invest Ophthalmol Vis Sci (2008) 1.03
A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology (2008) 1.02
Role of parental myopia in the progression of myopia and its interaction with treatment in COMET children. Invest Ophthalmol Vis Sci (2007) 1.02
Hypertension prevalence, control and survivorship in an Afro-Caribbean population. J Hypertens (2002) 1.00
Central adiposity and Prostate Cancer in a Black Population. Cancer Epidemiol Biomarkers Prev (2012) 0.99
Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol (2006) 0.98
Glaucoma detection using different Stratus optical coherence tomography protocols. Acta Ophthalmol Scand (2006) 0.97
Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology (2005) 0.97
Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial. Clin Trials (2005) 0.97
Machine learning classifiers for glaucoma diagnosis based on classification of retinal nerve fibre layer thickness parameters measured by Stratus OCT. Acta Ophthalmol (2010) 0.97
Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol (2004) 0.97
Risk factors for breast cancer in a black population--the Barbados National Cancer Study. Int J Cancer (2009) 0.96
Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer (2014) 0.96
Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology (2003) 0.96
Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes. Adv Ther (2010) 0.95
Variability of the ocular component measurements in children using A-scan ultrasonography. Optom Vis Sci (2004) 0.95
Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology (2005) 0.94
Factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol (2003) 0.94
Nine-year incidence of visual impairment in the Barbados Eye Studies. Ophthalmology (2009) 0.93
Open-angle glaucoma and mortality: The Barbados Eye Studies. Arch Ophthalmol (2008) 0.93
Evaluating the self-esteem of myopic children over a three-year period: The COMET Experience. Optom Vis Sci (2005) 0.93
Body size and breast cancer in a black population--the Barbados National Cancer Study. Cancer Causes Control (2008) 0.93
Factors associated with lifetime risk of open-angle glaucoma blindness. Acta Ophthalmol (2013) 0.92
Cost of atrial fibrillation in United States managed care organizations. Adv Ther (2009) 0.92
African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect Agent Cancer (2007) 0.92
Evaluation of the association between OPA1 polymorphisms and primary open-angle glaucoma in Barbados families. Mol Vis (2006) 0.91